or
forgot password

    • cancer clinical trials in memphis, TN

    • S0124: Cisplatin Combined With Either Irinotecan or Etoposide in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    University of Tennessee Cancer Institute - Medical Center
    Memphis, Tennessee 38104
    Lung Cancer
    S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium
    University of Tennessee Cancer Institute - Medical Center
    Memphis, Tennessee 38104
    Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer
    Carmustine Implants and O(6)-Benzylguanine in Treating Children With Recurrent Malignant Glioma
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Brain and Central Nervous System Tumors
    Oxaliplatin in Treating Children With Recurrent or Refractory Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Brain and Central Nervous System Tumors
    Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor
    Prialt (Ziconotide) In Severe Chronic Pain
    Methodist Comprehensive Pain Institute
    Memphis, Tennessee 38104
    Pain
    YM598 Added to Mitoxantrone/Prednisone to Control Pain in Metastatic Prostate Cancer Patients No Longer Responding to Hormone Therapy
    Memphis Cancer Center
    Memphis, Tennessee 38119
    Hormone-Refractory Prostate Cancer, Prostatic Neoplasms
    S0030: Capecitabine in Treating Older Patients W/Metastatic or Recurrent Colorectal Cancer That Cannot Be Surgically Removed
    Veterans Affairs Medical Center - Memphis

    Trial Locations
    Veterans Affairs Medical Center - Memphis
    University of Tennessee Cancer Institute at Methodist Central Hospital
    Colorectal Cancer
    Clinical Trial for Ovarian Cancer (OvaRex®)
    West Clinic, PC
    Memphis, Tennessee 38120
    Ovarian Cancer
    An Investigational Drug (CAL) Versus Zoledronic Acid (Zometa®) in Patients With Breast Cancer
    Boston Baskin Cancer Group

    Trial Locations
    Boston Baskin Cancer Group
    The West Clinic
    The Boston Baskin Cancer Group
    Breast Neoplasms, Breast Cancer, Metastasis
    S0125, Chemotherapy, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Older Patients With Acute Myeloid Leukemia
    University of Tennessee Cancer Institute at Methodist Central Hospital
    Memphis, Tennessee 38104
    Leukemia
    Irinotecan in Treating Patients With Refractory Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
    University of Tennessee Cancer Institute
    Memphis, Tennessee 38103
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
    Veterans Affairs Medical Center - Memphis

    Trial Locations
    Veterans Affairs Medical Center - Memphis
    University of Tennessee Cancer Institute at Methodist Central Hospital
    Malignant Mesothelioma
    S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the Urothelium
    University of Tennessee Cancer Institute at Methodist Central Hospital
    Memphis, Tennessee 38104
    Bladder Cancer, Urethral Cancer
    Exatecan Mesylate in Treating Children With Relapsed or Refractory Rhabdomyosarcoma
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Sarcoma
    Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer
    University of Tennessee Cancer Institute
    Memphis, Tennessee 38103
    Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms
    Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.
    University of Tennessee Cancer Institute
    Memphis, Tennessee 38103
    Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms
    S0227 Cisplatin With Either Paclitaxel or Gemcitabine in Recurrent, Persistent, or Metastatic Cervical Cancer
    University of Tennessee Cancer Institute
    Memphis, Tennessee 38103
    Cervical Cancer
    Comparative Trial for Pixantrone in Combination With Rituximab in Indolent Non-Hodgkin's Lymphoma
    The West Clinic
    Memphis, Tennessee 38120
    Lymphoma, Follicular, Lymphoma, Mixed-Cell, Follicular, Lymphoma, Small Cleaved-Cell, Follicular, Lymphoma, Low-Grade
    Safety and Effectiveness of ABT-510 Plus Combination Chemotherapy in Subjects With Non-Small Cell Lung Cancer (NSCLC)
    The West Cancer Clinic
    Memphis, Tennessee 38120
    Carcinoma, Non-Small-Cell Lung
    Study Evaluating the Safety and Effectiveness of ABT-510 in Subjects With Refractory Lymphoma
    The West Cancer Clinic
    Memphis, Tennessee 38120
    Lymphoma, Non-Hodgkin, Hodgkin's Lymphoma
    SR34006 Compared to Vitamin K Antagonist (VKA) in the Treatment of Pulmonary Embolism
    The West Cancer Clinic

    Trial Locations
    The West Cancer Clinic
    Baptist Memorial Hospital Memphis
    Pulmonary Embolism
    Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix
    University of Tennessee College of Medicine

    Trial Locations
    University of Tennessee College of Medicine
    Baptist Centers for Cancer Care
    Cervical Cancer
    Anidulafungin in Treating Immunocompromised Children With Neutropenia
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Infection, Neutropenia, Unspecified Childhood Solid Tumor, Protocol Specific
    Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen
    The West Clinic
    Memphis, Tennessee 38120
    Prostate Cancer, Hormone Refractory Prostate Cancer
    Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Previously Treated Childhood Rhabdomyosarcoma, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Recurrent Ewing Sarcoma, Peripheral Primitive Neuroectodermal Tumor
    Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's Lymphoma
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Lymphoma
    Surgery and/or Chemotherapy in Treating Children With Infantile, Congenital, or Childhood Fibrosarcoma
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Sarcoma
    A Study of ABT-751 in Patients With Renal Cell Cancer
    West Cancer Clinic
    Memphis, Tennessee 38120
    Renal Cell Cancer
    A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer
    West Cancer Clinic
    Memphis, Tennessee 38120
    Non-Small Cell Lung Cancer
    TP-38 Toxin in Treating Young Patients With Recurrent or Progressive Supratentorial High-Grade Glioma
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Brain and Central Nervous System Tumors
    Sleep, Fatigue, and Dexamethosone in Children With Leukemia
    St. Jude Children Research Hospital
    Memphis, Tennessee 38105
    Leukemia
    Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Adult Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma, Embryonal-botryoid Childhood Rhabdomyosarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma
    Pediatric Hypothalamic Obesity
    U of Tennessee HELP Center
    Memphis, Tennessee 38103
    Obesity
    Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Brain and Central Nervous System Tumors
    FR901228 in Treating Patients With Previously Treated Unresectable Locally Advanced or Metastatic Colorectal Cancer
    Veterans Affairs Medical Center - Memphis

    Trial Locations
    Veterans Affairs Medical Center - Memphis
    University of Tennessee Cancer Institute at Methodist Central Hospital
    Colorectal Cancer
    hu14.18-Interleukin-2 Fusion Protein in Treating Young Patients With Recurrent or Refractory Neuroblastoma
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Neuroblastoma
    Temozolomide in Treating Young Patients With Refractory or Recurrent Leukemia
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Leukemia
    Study of Therapy With TransMID™ Compared to Best Standard of Care in Patients With Glioblastoma Multiforme
    Semmes-Murphey Neurologic Institute
    Memphis, Tennessee 38104
    Glioblastoma Multiforme
    Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Primary CNS Germ Cell Tumor
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Brain Tumor, Central Nervous System Tumor
    LMB-2 Immunotoxin in Treating Young Patients With Relapsed or Refractory Leukemia or Lymphoma
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Leukemia, Lymphoma
    A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer Patients
    University of Tennessee Cancer Institute
    Memphis, Tennessee 38103
    Non-Small Cell Lung Cancer
    STA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)
    The West Clinic
    Memphis, Tennessee 38120
    Stage IIIB Non-Small Cell Lung Cancer, Stage IV Non-Small Cell Lung Cancer
    STA-5312 Administered on Alternate Weekdays Every Two Weeks to Patients With Hematologic Malignancies and Patients With Solid Tumors
    The West Clinic
    Memphis, Tennessee 38120
    Hematological Malignancies, Leukemia, Lymphoma, Metastatic or Unresectable Solid Tumors